Overview
- A surgeon at AdventHealth Celebration controlled a Toumai robotic system to perform a prostatectomy on a patient located at AdventHealth Minneola about 35 miles away, and the hospital said the patient is recovering well.
- The operation was conducted under an FDA investigational device exemption as part of an authorized clinical study and included an experienced bedside surgical team ready to intervene.
- AdventHealth and the lead surgeon said the case is investigational and does not mean the system is cleared for routine clinical use because safety and effectiveness remain under study.
- Investigators are explicitly evaluating network performance, latency and cybersecurity risks, since connection failures or equipment problems could endanger patients unless robust safeguards exist.
- The program builds on prior investigational links between Orlando and Luanda and will collect evidence on outcomes and technical reliability before any broader clinical rollout is considered.